Article Details
Retrieved on: 2021-01-12 16:18:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Toward the end of 2020, AstraZeneca splashed out $39 billion for Alexion to expand its immunology presence. That's a big price—and questions ...
Article found on: www.fiercepharma.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here